Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia
US6689787B1 · kind B1 · utility
19Cited by
49References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 5, 2001 |
| Grant date | Feb 10, 2004 |
| Priority date | — |
| Expiry date | Oct 5, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods to treat neoplasia disorders in a mammal using a combination of radiation and an integrin antagonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.